KIF20A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.030400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.226800E-01
Normal-vs-Stage2
1.724980E-01
Normal-vs-Stage3
2.960800E-01
Normal-vs-Stage4
4.453600E-01
Stage1-vs-Stage2
2.664400E-01
Stage1-vs-Stage3
5.771200E-01
Stage1-vs-Stage4
7.475000E-01
Stage2-vs-Stage3
7.725600E-01
Stage2-vs-Stage4
5.974600E-01
Stage3-vs-Stage4
8.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.074600E-01
Normal-vs-AfricanAmerican
2.207400E-01
Normal-vs-Asian
1.164150E-01
Caucasian-vs-AfricanAmerican
4.052200E-01
Caucasian-vs-Asian
6.483600E-01
AfricanAmerican-vs-Asian
4.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.139800E-01
Normal-vs-Female
1.984980E-01
Male-vs-Female
4.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.627200E-01
Normal-vs-Age(41-60Yrs)
1.663450E-01
Normal-vs-Age(61-80Yrs)
2.017800E-01
Normal-vs-Age(81-100Yrs)
2.127400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.239820E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.290360E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.613380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.920000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.312600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.818800E-01
Normal-vs-Daily Drinker
3.118800E-01
Normal-vs-Weekly Drinker
2.365000E-01
Normal-vs-Occasional Drinker
2.194800E-01
Normal-vs-Social Drinker
1.008240E-01
Non Drinker-vs-Daily Drinker
6.149000E-01
Non Drinker-vs-Weekly Drinker
4.717000E-01
Non Drinker-vs-Occasional Drinker
7.676200E-01
Non Drinker-vs-Social Drinker
6.187400E-01
Daily Drinker-vs-Weekly Drinker
2.653200E-01
Daily Drinker-vs-Occasional Drinker
4.424000E-01
Daily Drinker-vs-Social Drinker
3.043600E-01
Weekly Drinker-vs-Occasional Drinker
6.715800E-01
Weekly Drinker-vs-Social Drinker
7.788000E-01
Occasional Drinker-vs-Social Drinker
8.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.859800E-01
Normal-vs-Grade 2
6.963200E-01
Normal-vs-Grade 3
7.404400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.44699999996101E-06
Grade 1-vs-Grade 3
3.1736000000171E-06
Grade 1-vs-Grade 4
5.859800E-01
Grade 2-vs-Grade 3
1.614590E-01
Grade 2-vs-Grade 4
6.963200E-01
Grade 3-vs-Grade 4
7.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.650200E-01
Normal-vs-NonDiabetic
1.703180E-01
Diabetic-vs-NonDiabetic
1.413780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.370100E-02
Normal-vs-NoPancreatitis
2.361000E-01
Pancreatitis-vs-NoPancreatitis
5.732800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.568770E-01
Normal-vs-N1
1.964160E-01
N0-vs-N1
2.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.624200E-02
Normal-vs-TP53-NonMutant
2.690400E-01
TP53-Mutant-vs-TP53-NonMutant
1.96889999859451E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
